2 citations
,
May 2011 in “Journal of Clinical Oncology” This study found that paclitaxel poliglumex showed limited effectiveness and was relatively well tolerated in post-menopausal women with advanced NSCLC, suggesting further testing of this treatment may not be justified.
February 2024 in “Recima21” This study explored the connections between Covid-19 and hair loss issues like telogen effluvium and alopecia areata, highlighting the virus's potential trigger effect and underscoring the importance of comprehensive post-Covid-19 treatment strategies that consider immune, psychological, and hair cycle factors.
January 2012 in “Postgraduate obstetrics & gynecology” This descriptive abstract provides information about a continuing medical education activity for physicians, designating 1.5 credits for participation, but reports no new research findings.
April 2023 in “Voprosy kurortologii fizioterapii i lechebnoĭ fizicheskoĭ kultury” This study reported that 19.8% of patients experienced telogen hair loss after COVID-19, with most cases occurring 3 to 6 months post-recovery, and noted a rapid progression in patients with androgenetic alopecia, as well as cases of alopecia areata and cicatricial alopecia linked to COVID-19.
This study found that irregular menstrual cycles and weight gain were common among women with PCOS, with 87% and 64% of patients experiencing these symptoms, respectively.